Stay updated on InMed Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
Latest updates to the InMed Pharmaceuticals Press Releases page
- ChecktodayChange DetectedInMed has announced the results of its 2024 Annual General Meeting and entered into a Standby Equity Purchase Agreement, while recent financial results and an executive appointment have been removed from the site.SummaryDifference11%
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedInMed has announced the publication of a study on anti-inflammation through modulation of the endocannabinoid system, while previous announcements regarding a fireside chat on the pharmaceutical pipeline have been removed.SummaryDifference9%
- Check36 days agoChange DetectedInMed has reported its first quarter fiscal 2025 financial results and announced a share consolidation to comply with Nasdaq listing rules, while previous updates regarding 2024 milestones and the results of the 2023 annual general meeting have been removed.SummaryDifference10%
- Check43 days agoChange DetectedInMed Pharmaceuticals has announced a decision by the NASDAQ Hearings Panel to grant an exception for a share consolidation, while a previous announcement regarding the expansion of its pharmaceutical pipeline has been removed.SummaryDifference9%
- Check51 days agoChange DetectedInMed Pharmaceuticals has filed an additional patent application for INM-901 targeting neurodegenerative conditions, including Alzheimer's disease, while the previous report on their first quarter fiscal 2024 financial results has been removed.SummaryDifference7%
- Check58 days agoChange DetectedInMed is set to participate in a webinar on neuroinflammation related to Alzheimer's disease and has appointed Dr. Barry Greenberg to its Scientific Advisory Board, while recent announcements about a clinical study presentation and a private placement have been removed.SummaryDifference98%
Stay in the know with updates to InMed Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.